Advertisement

Topics

Novartis to cease antibiotic R&D despite superbug threat

05:46 EDT 13 Jul 2018 | pharmaphorum

Novartis has quit research and development into antibiotics, becoming the latest pharma giant to stop work in this field. The move is despite attempts by governments and other organisations across the world to find a new generation of antibiotics,...

Original Article: Novartis to cease antibiotic R&D despite superbug threat

NEXT ARTICLE

More From BioPortfolio on "Novartis to cease antibiotic R&D despite superbug threat"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...